Phase1, Open-Label, Dose Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer

Trial Profile

Phase1, Open-Label, Dose Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer

Suspended
Phase of Trial: Phase I

Latest Information Update: 24 Sep 2015

At a glance

  • Drugs SM 04755 (Primary)
  • Indications Colorectal cancer; Gastric cancer; Liver cancer; Pancreatic cancer
  • Focus Adverse reactions
  • Sponsors Samumed
  • Most Recent Events

    • 21 Sep 2015 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 23 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top